Staff editor
Prof. Flavia Indrio reflects on the main take-home messages from the congress, which brought together 32 leading international experts in microbiota research, allergy, nutrition, gut-brain axis and lung disease.
Paul Wilmes, University of Luxembourg, explores the concept of infective competence within a One Health framework.
The team developed a machine-learning model using 34 metabolites that could reliably identify depressed individuals.
Piergiorgio Natali (Mediterranean Task force for Cancer Control) discusses the importance of improving functional foods as a strategy to support health, particularly during aging.
Gut microbes can influence cancer outcomes by regulating nutrient availability and uptake in immune cells.
Lorenza Putignani, Pediatric Hospital Bambino Gesù, Italy, discusses translational research in the microbiome field.
Marika Falcone of San Raffaele Hospital in Milan discusses the growing evidence linking the gut microbiome to extra-intestinal autoimmune diseases.
Pierre Burguière, founder of Microbiome Futures, and Christian Roghi, founder of Bridgyz, reflect on a groundbreaking Pharmabiotics 2026 session dedicated to the intersection of microbiome science and space exploration.
Industry
Sponsored by
Visitors to booth #3C88 in Barcelona this May can explore how dsm-firmenich is unlocking increased health expectancy with the latest science-backed innovations targeting the cellular hallmarks of aging.
The study suggest that gut microbiota regulates key immune cells during pregnancy, and when this system is altered, the risk of pregnancy loss rises.
